Peijia Medical Limited (9996.HK)
HKD 4.69
(-2.7%)
HKD 4.69
(-2.7%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 441.12 Million | 250.83 Million | 136.53 Million | 38.65 Million | 18.69 Million | - |
| Cost of Revenue | 115.75 Million | 74.63 Million | 40.88 Million | 13.43 Million | 6.68 Million | - |
| Gross Profit | 325.37 Million | 176.2 Million | 95.65 Million | 25.22 Million | 12.01 Million | - |
| Operating Expenses | 756.13 Million | 618.74 Million | 694.45 Million | 2.13 Billion | 234.38 Million | 71.65 Million |
| Selling, General and Administrative Expenses | 466.61 Million | 365.06 Million | 207.67 Million | 139.09 Million | 51.21 Million | 8.61 Million |
| Research and Development Expenses | 293.42 Million | 383.65 Million | 454.42 Million | 109.44 Million | 55.13 Million | 27.85 Million |
| Other Expenses | -3.9 Million | 2.32 Million | -1.52 Million | 541 Thousand | 128.03 Million | 1.16 Million |
| Cost and Expenses | 871.88 Million | 693.38 Million | 735.33 Million | 2.14 Billion | 241.06 Million | 71.65 Million |
| Operating Income | -430.76 Million | -322.84 Million | -235.86 Million | -208.72 Million | -222.37 Million | -70.22 Million |
| Interest Expense | 178 Thousand | 2.31 Million | 186 Thousand | 91 Thousand | 823 Thousand | 163 Thousand |
| Income Tax Expense | 1.05 Million | 9.57 Million | 23.01 Million | 17.64 Million | 309.28 Million | 8.19 Million |
| Earnings before Tax | -391.5 Million | -398.23 Million | -574.21 Million | -2.06 Billion | -531.97 Million | -82.87 Million |
| Net Income | -392.52 Million | -407.8 Million | -574.21 Million | -2.06 Billion | -841.26 Million | -82.62 Million |
| Earnings Per Share Basic | -0.58 | -0.61 | -0.87 | -4.43 | -1.38 | -0.14 |
| Earnings Per Share Diluted | -0.58 | -0.61 | -0.87 | -4.43 | -1.38 | -0.14 |
| Weighted Average Shares Outstanding | 679.27 Million | 673.16 Million | 661.65 Million | 466.99 Million | 610.04 Million | 610.04 Million |
| Weighted Average Shares Outstanding (Diluted) | 679.27 Million | 673.16 Million | 661.65 Million | 466.99 Million | 610.04 Million | 610.04 Million |
| Gross Margin | 0.74 | 0.70 | 0.70 | 0.65 | 0.64 | - |
| EBIT Margin | -0.79 | -1.17 | -1.56 | -4.94 | -11.20 | - |
| Profit Margin | -0.89 | -1.63 | -4.21 | -53.52 | -44.99 | - |
| EBITDA | -348.52 Million | -359.9 Million | -546.54 Million | -190.87 Million | -209.35 Million | -67.12 Million |
| Earnings Before Tax Margin | -0.98 | -1.29 | -1.73 | -5.40 | -11.89 | - |
| Breakdown | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 FY |
|---|---|---|---|---|---|---|
| Revenue | 301.2 Million | 441.12 Million | 216.25 Million | 224.87 Million | 132.03 Million | 250.83 Million |
| Cost of Revenue | 82.33 Million | 115.75 Million | 63.84 Million | 51.91 Million | 39.03 Million | 74.63 Million |
| Gross Profit | 218.86 Million | 325.37 Million | 152.41 Million | 172.95 Million | 92.99 Million | 176.2 Million |
| Operating Expenses | 303.63 Million | 741.19 Million | 349.86 Million | 406.26 Million | 426.79 Million | 618.74 Million |
| Selling, General and Administrative Expenses | 214.19 Million | - | 232.14 Million | 234.47 Million | 212.78 Million | - |
| Research and Development Expenses | 100.54 Million | - | 132.21 Million | 172.58 Million | 300.22 Million | - |
| Other Expenses | -11.09 Million | -707 Thousand | -14.49 Million | - | - | 2.32 Million |
| Cost and Expenses | 385.97 Million | 856.95 Million | 413.7 Million | 458.17 Million | 465.82 Million | 693.38 Million |
| Operating Income | -84.77 Million | -430.76 Million | -197.45 Million | -143.25 Million | -185.18 Million | -322.84 Million |
| Interest Expense | - | 178 Thousand | - | - | - | 2.31 Million |
| Income Tax Expense | 2.8 Million | 1.05 Million | 450 Thousand | 602 Thousand | 9.38 Million | 9.57 Million |
| Earnings before Tax | -68.47 Million | -391.5 Million | -180.02 Million | -211.47 Million | -306.44 Million | -398.23 Million |
| Net Income | -71.27 Million | -392.52 Million | -180.46 Million | -212.06 Million | -315.82 Million | -407.8 Million |
| Earnings Per Share Basic | -0.10 | - | -0.26 | -0.31 | -0.47 | - |
| Earnings Per Share Diluted | -0.10 | - | -0.26 | -0.31 | -0.47 | - |
| Weighted Average Shares Outstanding | 679.37 Million | 679.27 Million | 681.13 Million | 677.41 Million | 674.14 Million | 673.16 Million |
| Weighted Average Shares Outstanding (Diluted) | 679.37 Million | 679.27 Million | 681.13 Million | 677.41 Million | 674.14 Million | 673.16 Million |
| Gross Margin | 0.73 | 0.74 | 0.70 | 0.77 | 0.70 | 0.70 |
| EBIT Margin | -0.21 | - | -0.76 | -0.56 | -1.29 | - |
| Profit Margin | -0.24 | -0.89 | -0.83 | -0.94 | -2.39 | -1.63 |
| EBITDA | -63.93 Million | - | -164.25 Million | -126 Million | -170.77 Million | - |
| Earnings Before Tax Margin | -0.28 | -0.98 | -0.91 | -0.64 | -1.40 | -1.29 |
TCLHF
UHRN
EVOTF
USAS
1683
BOCH